149 related articles for article (PubMed ID: 11750539)
1. Cytomegalovirus infection after liver transplantation using different prophylaxes.
Kornberg A; Grube T; Hommann M; Schotte U; Scheele J
Transplant Proc; 2001; 33(7-8):3624-5. PubMed ID: 11750539
[No Abstract] [Full Text] [Related]
2. Cytomegalovirus infection in kidney transplant recipients: early diagnosis and monitoring of antiviral therapy by the antigenemia assay.
Said T; Nampoory MR; Pacsa AS; Johny KV; Nair MP; Abdel-Haleem M; Samhan M; Al-Mousawi M
Transplant Proc; 2001 Aug; 33(5):2799-801. PubMed ID: 11498164
[No Abstract] [Full Text] [Related]
3. [Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease].
Aranda-Verástegui F; Alberú J; Soto-Ramírez LE; González-Aguirre H; Muñoz Trejo T; Mancilla E; Díliz H; Correa-Rotter R; Sierra-Madero J
Rev Invest Clin; 2002; 54(3):198-203. PubMed ID: 12183888
[TBL] [Abstract][Full Text] [Related]
4. Preemptive therapy for the prevention of cytomegalovirus disease following heart transplantation directed by PP65 antigenemia.
Villa M; Lage E; Ballesteros S; Cañas E; Sánchez M; Ordóñez A; Borrego JM; Hinojosa R; Cisneros JM
Transplant Proc; 2003 Mar; 35(2):732-4. PubMed ID: 12644115
[No Abstract] [Full Text] [Related]
5. CMV infection, diagnosis and antiviral strategies after liver transplantation.
Lautenschlager I
Transpl Int; 2009 Nov; 22(11):1031-40. PubMed ID: 19619175
[TBL] [Abstract][Full Text] [Related]
6. Ganciclovir prophylaxis of cytomegalovirus disease.
Conti DJ; Shen G; Singh T; Isenberg A; Freed BM
Transplant Proc; 1997; 29(1-2):804-6. PubMed ID: 9123534
[No Abstract] [Full Text] [Related]
7. Use of cytomegalovirus antigenemia as a marker for preemptive treatment.
Guirado L; Herreros MA; Muñoz JM; Rabella N; Facundo C; Agraz I; Díaz M; Diaz JM; Durán F; Solà R
Transplant Proc; 2002 Feb; 34(1):67-8. PubMed ID: 11959188
[No Abstract] [Full Text] [Related]
8. New immunosuppressive regimens and cytomegalovirus infection after kidney transplantation: a retrospective study.
Côté I; Deschêsnes L; de Cotret PR; Lachance JG; Noël R; Isenring P; Houde I
Transplant Proc; 2001; 33(7-8):3626-9. PubMed ID: 11750540
[No Abstract] [Full Text] [Related]
9. Monitoring of CMV infection after renal transplantation: serology, culture, and viral DNA detection by hybrid capture.
Flechner SM; Avery RK; Fisher R; Mastroianni B; Papajcik D; O'Malley KJ; Goormastic M; Goldfarb DA; Modlin CS; Novick AC
Transplant Proc; 1999; 31(1-2):1255-7. PubMed ID: 10083560
[No Abstract] [Full Text] [Related]
10. Guidance of ganciclovir therapy with pp65 antigenemia in cytomegalovirus-free recipients of livers from seropositive donors.
Grossi P; Kusne S; Rinaldo C; St George K; Magnone M; Rakela J; Fung J; Starzl TE
Transplantation; 1996 Jun; 61(11):1659-60. PubMed ID: 8669117
[No Abstract] [Full Text] [Related]
11. Prevention of cytomegalovirus disease after heart transplantation: preemptive therapy with 7 days' intravenous ganciclovir.
Paniagua MJ; Crespo-Leiro MG; De la Fuente L; Tabuyo T; Mosquera I; Cañizares A; Naya C; Fariña P; Juffé A; Castro-Beiras A
Transplant Proc; 2002 Feb; 34(1):69-70. PubMed ID: 11959189
[No Abstract] [Full Text] [Related]
12. Kidney recipient CMV incidence in the gancyclovir era: monitoring viral DNA by a CMV-PCR assay.
Cirocco RE; Ciancio G; Esquenazi V; Burke GW; Miller J
Transplant Proc; 1999; 31(1-2):1362-3. PubMed ID: 10083604
[No Abstract] [Full Text] [Related]
13. Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation.
Becker BN; Becker YT; Leverson GE; Simmons WD; Sollinger HW; Pirsch JD
Am J Kidney Dis; 2002 May; 39(5):1088-95. PubMed ID: 11979354
[TBL] [Abstract][Full Text] [Related]
14. The effect of sirolimus-based immunosuppression vs. conventional prophylaxis therapy on cytomegalovirus infection after liver transplantation.
Sheng L; Jun S; Jianfeng L; Lianghui G
Clin Transplant; 2015 Jun; 29(6):555-9. PubMed ID: 25851741
[TBL] [Abstract][Full Text] [Related]
15. [Cytomegalovirus hepatitis and ductopenia in a heart transplant recipient].
Pérez Calle JL; Salcedo M; Núñez O; Barrio J; Bañares R; de Diego A; Alvarez E; Palomo J; Clemente G
Gastroenterol Hepatol; 2003 Jan; 26(1):26-8. PubMed ID: 12525325
[No Abstract] [Full Text] [Related]
16. Cytomegalovirus infection after kidney transplantation and long-term graft loss.
López-Oliva MO; Flores J; Madero R; Escuin F; Santana MJ; Bellón T; Selgas R; Jiménez C
Nefrologia; 2017; 37(5):515-525. PubMed ID: 28946964
[TBL] [Abstract][Full Text] [Related]
17. Evaluating sirolimus-based immunosuppression for the prevention of cytomegalovirus replication after liver transplantation.
Arasaratnam RJ
Clin Transplant; 2015 Sep; 29(9):723. PubMed ID: 26265556
[No Abstract] [Full Text] [Related]
18. Cytomegalovirus infection in marrow transplantation.
Boeckh M; Bowden R
Cancer Treat Res; 1995; 76():97-136. PubMed ID: 7577347
[No Abstract] [Full Text] [Related]
19. Incidence and therapy of cytomegalovirus disease after liver transplantation.
Wiens M; Lefèbre B; Blumhardt G; Schmidt CA; Lohmann R; Neuhaus P
Transplant Proc; 1993 Apr; 25(2):1985-6. PubMed ID: 8385829
[No Abstract] [Full Text] [Related]
20. Preemptive oral ganciclovir therapy versus prophylaxis to prevent symptomatic cytomegalovirus infection after kidney transplantation.
Jung C; Engelmann E; Borner K; Offermann G
Transplant Proc; 2001; 33(7-8):3621-3. PubMed ID: 11750538
[No Abstract] [Full Text] [Related]
[Next] [New Search]
